The new report by Expert Market Research titled, ‘Global Cancer Cachexia Market Size, Report and Forecast 2022-2027’, gives an in-depth analysis of the global cancer cachexia market, assessing the market based on its segments like therapeutics, mechanisms of action, distribution channels, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/cancer-cachexia-market/requestsample
The key highlights of the report include:
Market Overview (2017-2027)
- Forecast CAGR (2022-2027): 7%
Rising cases of cancer and cancer cachexia and advancements in current treatment methods are projected to increase the global market for cancer cachexia. The prevalence of cachexia in North America, Japan, and Europe will make these key cancer cachexia markets in the forecast period. The rise in demand for therapy drugs acts as the major factor driving the cancer cachexia market globally. Furthermore, the advent of pipeline medicines and technical advancements in the cancer cachexia market would provide lucrative possibilities to companies in the forecast years. Another major factor driving market expansion is the rising occurrence of cachexia among the geriatric population.
Industry Definition and Major Segments
Cachexia is a severe health issue of several chronic illnesses linked to low quality of life. Cachexia affects 5–15 percent of those with advanced chronic heart failure and 50–80 percent of people with advanced cancer. Many people with chronic obstructive pulmonary disease (COPD), chronic renal disease, and rheumatoid arthritis experience cachexia as they approach the end of their lives. Cachectic syndrome is a significant cause of morbidity and mortality in cancer patients.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/cancer-cachexia-market
By therapeutics, the market is divided into:
- Combination Therapy
By mechanism of action, the market is classified into:
- Appetite Stimulators
- Weight Loss Stabilisers
By distribution channel, the market is segmented into:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
On the basis of region, the market is segmented into:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
The rise in a number of research and development activities for the identification of therapeutic medications and their high demand among consumers and expanding technical improvements for the treatment of cancer cachexia fuels the cancer cachexia market expansion. The cancer cachexia market is influenced by an increase in investments in cutting-edge drug research that results in novel, sophisticated medicines with a specific mechanism of action and a greater focus on palliative cancer care. Moreover, global population growth, rising healthcare expenditures, improved healthcare infrastructure, and increased awareness all benefit the cancer cachexia market. The presence of a large number of drug manufacturers and the advancing paradigm of care for cancer patients is supporting the growth of the market globally.
Key Market Players
The major players in the market are Merck & Co., Inc., Aphios Corporation, Helsinn Healthcare SA, AVEO Pharmaceuticals, Inc., Ono Pharmaceutical Co., Ltd., and Pfizer Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Media Contact: Company Name: Claight Corporation
Contact Person: Shira Ellis, Corporate Sales Specialist — U.S.A.
Email: [email protected]
Toll Free Number: +1–415–325–5166 | +44–702–402–5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA